Current Use and Complementary Value of Combining in Vivo Imaging Modalities to Understand the Renoprotective Effects of Sodium-Glucose Cotransporter-2 Inhibitors at a Tissue Level

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) were initially developed to treat diabetes and have been shown to improve renal and cardiovascular outcomes in patients with- but also without diabetes. The mechanisms underlying these beneficial effects are incompletely understood, as is the respon...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Hoek, Sjoukje, Stevens, Jasper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899288/
https://www.ncbi.nlm.nih.gov/pubmed/35264970
http://dx.doi.org/10.3389/fphar.2022.837993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899288/
https://www.ncbi.nlm.nih.gov/pubmed/35264970
http://dx.doi.org/10.3389/fphar.2022.837993

Ejemplares similares